MEDANTA · Hospitals & Diagnostics
Global Health Limited
- Company snapshot
- 2026-11-11
- Latest available quarter
- 2026-09-30Consolidated
- Ownership quarter
- 2026-09-30
COMPANY COMPARISON · NSE
Compare business size, valuation, growth and ownership. Higher or lower does not automatically mean better.
MEDANTA · Hospitals & Diagnostics
NH · Hospitals & Diagnostics
Choose a metric group. Tap a metric’s explanation button for context.
19 metrics shown
| Metric | MEDANTA | NH |
|---|---|---|
| Price | ₹1,429 | ₹1,866.4 |
| Market cap | ₹38,376 cr | ₹38,665 cr |
| P/E | 62.2 | 44.1 |
| P/B | 8.9 | 7.6 |
| ROE | 15.1% | 19.8% |
| ROCE | 13.2% | 14.5% |
| Debt / equity | 0.3 | 1.29 |
| Operating margin | 16.8% | 12.7% |
| Dividend yield | 0.04% | 0.24% |
| Sales growth, 3 years (yearly) | 17.2% | 20.4% |
| Profit growth, 3 years (yearly) | 19.5% | 9.9% |
| 1-year return | 20.1% | 2.8% |
| Revenue, last 12 months | ₹5,053 cr | ₹10,273 cr |
| Net profit, last 12 months | ₹618 cr | ₹859 cr |
| Latest available quarter | Sept 2026 | Sept 2026 |
| Quarter net profit | ₹219 cr | ₹301 cr |
| Quarter profit vs a year earlier | +38.3% | +16.5% |
| Promoter holding | 33.00% | 63.27% |
| Health check | Strong (7.2/10) | Strong (6.8/10) |